GTG at the moment appears to have minimal downside risk. By that I mean a complete re-rating downwards, not the day to day fluctuations. The license contracts should have put some sort of safety net under this stock. Impossible as it is for me to put a value on GTG at the moment the only downside risk I see would be a sudden halt in the licenses being granted. And that ain't gunna happen!
So, the risk / reward looks pretty attractive.
However, anything can and does happen!
Is there a better BioTech at the moment? I don't think there is.
Go you little ripper!!!!!!!!!!!!!
The downside risk
Add GTG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $36.93M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $29.2K | 7.300M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 91 | 97189844 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 27021587 | 29 |
View Market Depth
| Last trade - 11.00am 25/05/2022 (20 minute delay) ? |
 (live)
|
|||||
|
Last
0.4¢ |
Change
0.001 ( 16.7 %) |
||||
| Open | High | Low | Volume | ||
| 0.4¢ | 0.4¢ | 0.4¢ | 4100000 | ||
| Last updated 13.48pm 25/05/2022 (live) ? | |||||
| GTG (ASX) Chart |